Viewing Study NCT02575404


Ignite Creation Date: 2025-12-24 @ 9:22 PM
Ignite Modification Date: 2026-01-02 @ 6:52 AM
Study NCT ID: NCT02575404
Status: COMPLETED
Last Update Posted: 2023-06-05
First Post: 2015-10-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: GR-MD-02 Plus Pembrolizumab in Melanoma, Non-small Cell Lung Cancer, and Squamous Cell Head and Neck Cancer Patients
Sponsor: Providence Health & Services
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module